“…Nanotechnology‐based agents will be developed during the next decade for MRI (Neuwalt et al., 2004; Schellenberger et al., 2002; Harishingani et al., 2003; Li et al., 2004; Kircher et al., 2003), X‐ray/CT (Srinivas et al., 2002; Rabin et al., 2006; Hainfeld et al., 2006), optical (Itoh and Osamura, 2007; Gao et al., 2005; Chan et al., 2002; Min‐Ho Lee, 2006) and ultrasound imaging (Liu et al., 2006, 2007; Wheatley et al., 2006) Nanoparticles are being developed as bi‐modal imaging agents (Mulder et al., 2006; Li et al., 2006) for MR/CT and MR/optical imaging.…”